ArticleJournal of immunotherapy (Hagerstown, Md. : 1997)

First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis.

Chang-Ting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.